Literature DB >> 21763961

Epidemiology of renal cell cancer.

Eunyoung Cho1, Hans-Olov Adami, Per Lindblad.   

Abstract

Renal cell cancer (RCC) is increasingly diagnosed at an early stage in many countries, which likely contributes to the recent leveling of RCC mortality in the United States and many European countries. However, over all stages nearly 50% of the patients die within 5 years after diagnosis. Smoking and obesity may account for approximately 40% of all incidental cases in high-risk countries. Besides obesity, rising prevalence of hypertension may play a growing role. Several other occupational and lifestyle factors may also affect the risk of RCC. Genetic variations may be an important factor in the differing incidence among populations.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763961     DOI: 10.1016/j.hoc.2011.04.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  39 in total

1.  Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990-2009.

Authors:  Jun Li; Hannah K Weir; Melissa A Jim; Sallyann M King; Reda Wilson; Viraj A Master
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

Review 2.  The microbiome of the urinary tract--a role beyond infection.

Authors:  Samantha A Whiteside; Hassan Razvi; Sumit Dave; Gregor Reid; Jeremy P Burton
Journal:  Nat Rev Urol       Date:  2015-01-20       Impact factor: 14.432

Review 3.  Role of percutaneous needle biopsy for renal masses.

Authors:  Elaine M Caoili; Matthew S Davenport
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

Review 4.  Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma.

Authors:  David M Gill; Andrew W Hahn; Peter Hale; Benjamin L Maughan
Journal:  Curr Treat Options Oncol       Date:  2018-01-24

5.  Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method.

Authors:  Christian Niedworok; Frank vom Dorp; Stephan Tschirdewahn; Herbert Rübben; Henning Reis; Miklos Szucs; Tibor Szarvas
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

6.  Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Authors:  Alexander S Parker; Jeanette E Eckel-Passow; Daniel Serie; Tracy Hilton; Mansi Parasramka; Richard W Joseph; Kevin J Wu; John C Cheville; Bradley C Leibovich
Journal:  Eur Urol       Date:  2013-12-25       Impact factor: 20.096

7.  Vitamin D-Binding Protein and Risk of Renal Cell Carcinoma in the Cancer Prevention Study-II Cohort.

Authors:  Marjorie L McCullough; Demetrius Albanes; Alison M Mondul; Stephanie J Weinstein; Dominick Parisi; Caroline Y Um
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-20       Impact factor: 4.254

8.  Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.

Authors:  Giuseppe Simone; Gabriele Tuderti; Umberto Anceschi; Rocco Papalia; Mariaconsiglia Ferriero; Leonardo Misuraca; Francesco Minisola; Riccardo Mastroianni; Manuela Costantini; Salvatore Guaglianone; Steno Sentinelli; Michele Gallucci
Journal:  World J Urol       Date:  2016-08-30       Impact factor: 4.226

9.  Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.

Authors:  Alison M Mondul; Stephanie J Weinstein; Kristin A Moy; Satu Männistö; Demetrius Albanes
Journal:  Int J Cancer       Date:  2014-01-30       Impact factor: 7.396

10.  Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies.

Authors:  Toni K Choueiri; Youjin Je; Eunyoung Cho
Journal:  Int J Cancer       Date:  2013-09-23       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.